Carolyn C. Tang, General Counsel at Arcus Biosciences, Inc. (RCUS), sold 28,936 shares at $21.88 ($637K) on 2025-12-16, disclosed to the SEC on 2025-12-18.
Scheduled sale ($637k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.88 | 7,658 | $168K | 26.3% |
| 2 | $21.88 | 7,658 | $168K | 26.3% |
| 3 | $22.16 | 6,810 | $151K | 23.7% |
| 4 | $22.16 | 6,810 | $151K | 23.7% |
| Total | $22.01 avg | 28,936 | $637K | 100% |
| Filing → |
| RCUS | SELL | 2021-12-20 | $44K | — | Filing → |
| RCUS | SELL | 2021-06-21 | $70K | — | Filing → |